Overview
Antonio Guerrero-Mendez practices in Madrid, Spain. Mr. Guerrero-Mendez is rated as an Experienced expert by MediFind in the treatment of Neuronal Intranuclear Inclusion Disease (NIID). His top areas of expertise are Miller-Fisher Syndrome, Encephalitis Lethargica, Drug Induced Dyskinesia, and Brown Syndrome.
His clinical research consists of co-authoring 31 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Neuronal Intranuclear Inclusion Disease (NIID).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Drug Induced DyskinesiaMr. Guerrero-Mendez isAdvanced. Learn about Drug Induced Dyskinesia.
- Encephalitis LethargicaMr. Guerrero-Mendez isAdvanced. Learn about Encephalitis Lethargica.
- Miller-Fisher SyndromeMr. Guerrero-Mendez isAdvanced. Learn about Miller-Fisher Syndrome.
- Experienced
- 47 XYY SyndromeMr. Guerrero-Mendez isExperienced. Learn about 47 XYY Syndrome.
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- Brown SyndromeMr. Guerrero-Mendez isExperienced. Learn about Brown Syndrome.
- Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
- Corticobasal DegenerationMr. Guerrero-Mendez isExperienced. Learn about Corticobasal Degeneration.
- COVID-19Mr. Guerrero-Mendez isExperienced. Learn about COVID-19.